Grand received in 2020

DCCC has funded 200,000 DKKK to the preparation of this national and multidisciplinary investigator-initiated study.

Pancreatic cancer is a very deadly disease, and only very few survive after 5 years. It is known, that Circulating tumour (ct)DNA is a strong indicator for recurrence and survival. This study will investigate if circulating ctDNA in blood among patients with pancreatic cancer, who can be operated, can give better treatment, increased survival ship and identify recurrence earlier than CT-scanning.

Multidisciplinary organisation

Study preparations are done in collaboration with the Danish Pancreas Cancer Group (DPCG) and the study will be anchored in DCCC Danish Research Centre for circulating tumour DNA guided treatment.

Project stakeholders

  • Prof. Julia Sidenius Johansen, Dept. of Oncology, Herlev & Gentofte Hospital, University of Copenhagen. Primary contact, mail: Julia.Sidenius.Johansen@regionh.dk
  • Prof. Claus Lindbjerg Andersen, Dept. of Molecular Meidicne (MOMA), Aarhus University Hospital
  • Prof. Sönke Detlefsen, Dept. of Pathology, Odense University Hospital
  • Dr. Benny Vittrup, Dept. of Oncology, Herlev & Gentofte Hospital, University of Copenhagen
  • Dr. Inna Chen, Dept. of Oncology, Herlev & Gentofte Hospital, University of Copenhagen
  • Dr. Sidsel Christy Lindgaard, Dept. of Oncology, Herlev & Gentofte Hospital, University of Copenhagen
  • Prof. Dorte Nielsen, Dept. of Oncology, Herlev & Gentofte Hospital, University of Copenhagen
  • Prof. Stig E. Bojesen, Dept. of Clinical Biochemistry, Herlev & Gentofte Hospital, University of Copenhagen
  • Prof. Estrid Høgdall, Dept. of Pathology, Herlev & Gentofte Hospital, University of Copenhagen
  • Prof. Michael Bau Mortensen, Dept. of Surgery, Odense University Hospital
  • Dr. Claus Fristrup, Dept. of Surgery, Odense University Hospital
  • Prof. Per Pfeiffer, Dept. of Oncology, Odense University Hospital
  • Karin de Stricker, Dept. of Pathology, Odense University Hospital
  • Dr. Trine Aaquist, Dept. of Pathology, Odense University Hospital
  • Dr. Carsten Palnæs Hansen, Dept. of Surgery, Rigshospitalet, University of Copenhagen
  • Dr. Jan Henrik Storkholm, Dept. of Surgery, Rigshospitalet, University of Copenhagen
  • Dr. Stefan Kobbelgaard Burgdorf, Dept. of Surgery, Rigshospitalet, University of Copenhagen
  • Dr. Jane Preuss Hasselby, Dept. of Pathology, Rigshospitalet, University of Copenhagen
  • Prof. Ole Thorlacius Ussing, Dept. of Gastrointestinal Surgery, Aalborg University Hospital
  • Dr. Mogens Sall, Dept. of Gastrointestinal Surgery, Aalborg University Hospital
  • Prof. Morten Ladekarl, Dept. of Oncology, Aalborg University Hospital
  • Dr. Mette Karen Yilmaz, Dept. of Oncology, Aalborg University Hospital
  • Dr. Louise Skau Rasmussen, Dept. of Oncology, Aalborg University Hospital
  • Prof. Frank Viborg Mortensen, Dept. of Surgery, Aarhus University Hospital
  • Prof. Stephen Hamilton-Dutoit, Dept. of Pathology, Aarhus University Hospital
  • Dr. Britta Weber, Dept. of Oncology, Aarhus University Hospital
  • Prof. Niels Pallisgaard, Dept. of Pathology, Zealand University Hospital, Roskilde
  • Prof. Jes Søgaard, Danish Center for Health Economics, University of Southern Denmark
  • Liza Sopina, Danish Center for Health Economics, University of Southern Denmark

News

DCCC Strengthens Danish Cancer Research With 1.7 Million DKK, November 27, 2020